Table 1.
No. | Components of Nanoparticles | Method of Preparation | Polyphenol + Synergistic Agent | Type of Cancer In Vitro Model/In Vivo Model Promisingly Ttreated with the Fabricated Nanotherapeutic Formulation | References |
---|---|---|---|---|---|
1 | Polyvinyl pyrrolidone–PEG | Emulsion evaporation | Plant polyphenols | Glioblastoma DBTRG-05MG | [28] |
2 | Keratin | Solvent evaporation | Curcumin | Cervical cancer HeLa | [29] |
3 | Gelatin | Solvent evaporation | Curcumin | Lung cancer H1299 | [30] |
4 | PEG–Oleic acid | Thin layer evaporation | Curcumin | Brain cancer U87MG | [42] |
PEG: polyethylene glycol.